IL22 and psoriasis: reported a liposome gel containing CsA-loaded cationic liposomes, which could dramatically reduce psoriasis symptoms and the level of psoriatic cytokines (e.g., TNF-α, IL-17, and IL-22) after topical administration to an IMQ-induced psoriatic plaque model (72).